Articles, App Notes, Case Studies, & White Papers

1. Layer By Layer: 3D Screen Printing And The Future Of Drug Development 8/15/2025

   3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.

2. When Glass Vials Fail At Low Temps, Consider A Cyclic Olefin Polymer System

   If the glass vial for a biologic drug experiences breakage, or does not maintain container closure integrity, a cyclic olefin polymer (i.e., Daikyo Crystal Zenith COP) system may be the solution.

3. Drug Formulation Development: Quick Reference Guide 7/11/2022

   This guide shares the steps involved in formulation development, considerations during formulation, and how partnering with an experienced CDMO can lead to a successful commercial product.

4. Lyophilized Products Are On The Rise: What You Need To Know 2/18/2022

   There is increased demand for lyophilization services in the manufacturing of new biologic drugs and injectable formulations as well as in change of formulation presentation.

5. Liquid Capsule Manufacturing: What To Know 5/4/2022

   Capsules surround a drug in an unflavored, solid barrier enclosure. This article focuses on liquid capsule manufacturing and its advantages.

6. FAQs On The Revised EU GMP Annex 1: Volume 8 2/4/2026

   Successfully implementing a site-wide CCS requires prioritizing barrier technologies, integrating primary packaging into risk assessments, and adopting a data-driven approach to environmental monitoring.

7. Engineering Approaches To Respiratory Drug Delivery 5/27/2022

   Explore the material and performance properties of spray-dried and jet-milled mannitol for respiratory delivery of crystalline mannitol.

8. The Role Of Psychological Principles In Med Device Training Design 6/19/2024

   Explore how psychological principles can shape the design of medical device training and the significance of these principles in developing an effective training protocol for new medical device users.

9. From Regulators To PUPSIT: Notes On Annex 1 Revision Implementation 5/26/2023

   Kevin Smyth, a biochemical engineer with 30 years of experience in the pharmaceutical industry, offers insights and expertise in working with firms to understand what regulators seek to meet new standards.

10. Off-The-Shelf Vs. Novel Devices: Selecting A Drug Delivery System 4/19/2022

    Whether bringing a novel therapy to market or altering current devices, companies must determine the best selection for administration without impacting drug efficacy, quality, and safety.